Abstract
Background Cooling is the single most eff ective treatment for acute neuronal injury. Understanding the molecular mechanisms that mediate cooling-induced neuroprotection might yield novel therapeutic targets for neurodegenerative disease. Many of these disorders involve modulation of tau, a protein that is enriched in neurons and becomes hyperphosphorylated in hypothermic, injury-resistant rodent brains as well as in Alzheimer's disease. We sought to establish a new model for exploring human tau physiology and its role in neuroprotection in the context of therapeutic hypothermia.
Methods Functional cortical neurons (hCNs) were diff erentiated from three independent human pluripotent stemcell lines and validated for regional identity and tau status. Matched cultures were incubated at 37°C or clinically targeted temperatures for therapeutic hypothermia (32°C) and suspended animation (28°C). Eff ects of cooling on tau status and neuronal injury elicited by common neurotoxic stressors were established. Injury experiments were repeated while manipulating tau phosphorylation.
Findings hCN diff erentiation featured transitions in tau status, recapitulating transcriptional and post-translational human in-vivo cortical tau development. Key aspects of this development were reversed by cooling. Notably, cooling induced tau hyperphosphorylation via rapid inhibition of the major tau phosphatase, protein phosphatase 2A (PP2A). Multiplexed injury analysis confi rmed that hypothermia robustly protected hCNs from oxidative (100 μM hydrogen peroxide) and excitotoxic (30 μM glutamate) stress (at 28°C, injury was reduced by 78% and 56%, respectively; p<0·0005). Selective block of a major tau kinase reduced hCN tau phosphorylation and abrogated hypothermic protection (p=0·001) against oxidative injury at 28°C (injury reduction diminished to 9% at 100 μM hydrogen peroxide), whereas pharmacological inhibition of PP2A mimicked cooling-induced tau phosphorylation and protected hCNs from oxidative injury at 37°C (up to 22% injury reduction [p=0·008], with no benefi t under hypothermic conditions).
Interpretation To our knowledge, this is the fi rst study of human neuronal tau physiology under hypothermic conditions. Although defi nitive experiments are needed, our fi ndings support previous work linking phospho-tau to neuroprotection. Furthermore, cold-induced tau hyperphosphorylation is a potential trigger for proteostatic priming, a recently discovered mechanism of hypothermic preconditioning in hCNs. Exploiting these cryobiological eff ects might lead to new treatments for acute and chronic neuronal injury.
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